Evidence map›Paper›PMID 23086378›Full record

ArticleOrganogenesis

Development of embryonic stem cells in recombinant kidneys.

Aleksandra Rak-Raszewska, Bettina Wilm, David Edgar, Simon Kenny, Adrian S Woolf, Patricia Murray

Open access · hybridAbstract read
In one paragraph

Article in Organogenesis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Growing a new human kidney.Kidney international · 2019
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Direct transcriptional reprogramming of adult cells to embryonic nephron progenitors.Journal of the American Society of Nephrology : JASN · 2013
    Article
  14. Article
  15. Autologous Cells for Kidney Bioengineering.Current transplantation reports
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Aleksandra Rak-RaszewskaInstitute of Translational Medicine; the University of Liverpool; Liverpool, UK.
Bettina Wilm
David Edgar
Simon Kenny
Adrian S Woolf
Patricia Murray
University of Liverpool · GBAlder Hey Children's NHS Foundation Trust · GBRoyal Manchester Children's Hospital · GB

Funding

Medical Research Council G0300296
6 · The paper itself

Abstract

Embryonic stem cells (ESC) are self-renewing and can generate all cell types during normal development. Previous studies have begun to explore fates of ESCs and their mesodermal derivatives after injection into explanted intact metanephric kidneys and neonatal kidneys maturing in vivo. Here, we exploited a recently described recombinant organ culture model, mixing fluorescent quantum dot labeled mouse exogenous cells with host metanephric cells. We compared abilities of undifferentiated ESCs with ESC-derived mesodermal or non-mesodermal cells to contribute to tissue compartments within recombinant, chimeric metanephroi. ESC-derived mesodermal cells downregulated Oct4, a marker of undifferentiated cells, and, as assessed by locations of quantum dots, contributed to Wilms' tumor 1-expressing forming nephrons, synaptopodin-expressing glomeruli, and organic ion-transporting tubular epithelia. Similar results were observed when labeled native metanephric cells were recombined with host cells. In striking contrast, non-mesodermal ESC-derived cells strongly inhibited growth of embryonic kidneys, while undifferentiated ESCs predominantly formed Oct4 expressing colonies between forming nephrons and glomeruli. These findings clarify the conclusion that ESC-derived mesodermal cells have functional nephrogenic potential, supporting the idea that they could potentially replace damaged epithelia in diseased kidneys. On the other hand, undifferentiated ESCs and non-mesodermal precursors derived from ESCs would appear to be less suitable materials for use in kidney cell therapies.

Indexed as

AnimalsBiomarkersCell CountCell Culture TechniquesCell DifferentiationCell ProliferationChimeraEmbryonic Stem CellsGene ExpressionGreen Fluorescent ProteinsKidneyKidney TubulesMesodermMiceOctamer Transcription Factor-3Organ Culture TechniquesBiomarkersGreen Fluorescent ProteinsOctamer Transcription Factor-3Pou5f1 protein, mousedifferentiationembryonic stem cellkidneymesodermmetanephrosnephrogenesisorganic anion transportquantum dotrudiment

Identifiers

PMID23086378
PMCPMC3562253
OpenAlexW2125306992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.